126376-44-1

Basic information

• Product Name: 2-Methyl-3-phenyl-propane-1,2-diamine
• Synonyms: 2-Methyl-3-phenyl-propane-1,2-diamine
• CAS NO: 126376-44-1
• Molecular Formula: C₁₀H₁₆N₂
• Molecular Weight: 164.24744
• Mol File: 126376-44-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Methyl-3-phenyl-propane-1,2-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methyl-3-phenyl-propane-1,2-diamine(126376-44-1)
• EPA Substance Registry System: 2-Methyl-3-phenyl-propane-1,2-diamine(126376-44-1)

Safety Data

• Hazardous Substances Data: 126376-44-1(Hazardous Substances Data)

Upstream product

• 103-79-7 1-phenyl-acetone 
• 28385-45-7 L-α-methylphenylalanine methyl ester 
• 64384-47-0 2-amino-3-phenyl-2-methylpropanenitrile 

Downstream Products

• 126376-56-5 (DL-2-benzyl-1,2-propanediamine)dichloroplatinum(II) 

Relevant articles and documents

Substituted indolizine-like compounds and methods of use

Selected novel substituted indolizine-like compounds are effective for treatment of diseases, such as TNF-α, IL-1β, IL-6 and/or IL-8 mediated diseases, and other maladies, such as cancer, pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for treatment of diseases and other maladies or conditions involving inflammation, cancer, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted pyrimidinone and pyridone compounds and methods of use

Selected novel substituted pyrimidinone and pyridone compounds are effective for prophylaxis and treatment of diseases, such as TNF- alpha , IL-1 beta , IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.